Is Healthcare Innovation's Next Challenge Alignment, or Technology?

One of the loudest messages from this year's HLTH conference in Amsterdam was that healthcare innovation is no longer primarily a technology challenge. It is an alignment challenge. Across discussions ranging from the obligatory AI and machine learning to predictive analytics and population health management, to early detection, digital health and integrated care, the scale of opportunity is almost overwhelming. Healthcare has never had access to more sophisticated tools to identify risk earlier, personalise interventions, improve clinical decision-making and support better outcomes at both individual and population levels. Yet, what is clear, is that technology alone will not transform healthcare.

True transformation in healthcare is not achieved through innovation alone, but through the successful translation of innovation into routine practice. This requires navigating a complex pathway that includes regulation, evidence generation, procurement, funding, clinical adoption and large-scale implementation. The challenge is no longer proving that a solution can work, but demonstrating that it can deliver measurable value, gain trust and be sustainably embedded within healthcare systems. This involves buy-in from clinician users on the ground, and at the patient level. The gap between promising innovation and meaningful population-level impact remains one of healthcare’s most significant barriers to progress.

Several speakers emphasised that this challenge is unfolding against a backdrop of mounting structural pressures. Healthcare systems worldwide are grappling with workforce shortages, rising demand, ageing populations, constrained budgets, fragmented service delivery and persistent inequalities in access to care. At the same time, interoperability continues to limit the seamless flow of data, while expectations around evidence, safety, governance and accountability are becoming increasingly stringent. In this context, the innovations most likely to succeed will be those that address real system needs and can demonstrate clear clinical, operational and economic value at scale.

For innovators, founders, investors and operators, this creates both friction and opportunity. The challenge is not simply building solutions, but understanding how those solutions fit within complex systems, create measurable value and improve outcomes for patients, clinicians and communities. Crucially, will you get buy-in from the ultimate users of the technology, as that can be the key between success and failure.

A recurring theme throughout the conference was the growing importance of place-based innovation and digitally enabled community health models. Discussions highlighted the need for stronger alignment between primary and secondary care, health and social care, prevention and treatment, public health and health literacy. Many developed healthcare systems have evolved in ways that create silos between these functions. However, the greatest opportunities increasingly sit at these intersections that lead to structurally integrated care models. Integrated care models, supported by data, technology and collaboration, have the potential to improve coordination, reduce inefficiencies and create a more connected patient experience, but achieving this requires more than innovation; it requires partnerships, and alignment across the health and care ecosystem.

The phrase “it takes an ecosystem to innovate” emerged on several occasions throughout the discussions, reflecting a growing recognition that healthcare transformation is fundamentally a collective endeavour. No single organisation, technology or stakeholder group can deliver meaningful change in isolation. Lasting impact depends on effective collaboration between providers, industry, policymakers, researchers, funders, regulators and patients, with each playing a distinct but interconnected role in the innovation pathway.

The discussion highlighted that success is not simply about bringing stakeholders together, but about aligning incentives, defining shared outcomes and establishing mechanisms that reward both health and economic value. Without this alignment, even the most promising innovations risk becoming trapped in pilots or fragmented implementation. Sustainable transformation therefore requires a coordinated ecosystem that can accelerate adoption, share risk, generate evidence and create the conditions for innovation to deliver measurable benefits at scale.

Prevention and Wellness: Who Pays?

Another major discussion centred on the future of primary care and the shift from managing illness to supporting healthspan. Prevention, wellness, health education and early intervention are becoming increasingly central to healthcare strategy. Advances in predictive analytics, population modelling and risk stratification create opportunities to identify needs earlier and intervene more effectively. However, this shift raises a fundamental question: who pays for prevention? Governments, health systems, insurers, employers and individuals all benefit from healthier populations. Yet prevention creates a unique economic challenge because the benefits are often delayed and distributed across multiple stakeholders. It is always difficult to “prove the negative” and show the return on investment (whether through taxation or self-pay) on illnesses that never occurred.

The organisation funding an intervention today may not be the organisation that captures the return on that investment later. This creates a challenge and an opportunity for healthcare systems because prevention generates value, but traditional funding and reimbursement models often struggle to recognise whole-system benefits. The question is therefore not only whether prevention works, but how funding models can evolve to reward long-term outcomes rather than short-term budget cycles.

Across all sessions, one final theme stood out: the value of data. Not collecting more data for its own sake, but using data to generate actionable insights that improve patient journeys, strengthen clinical decision-making and deliver better outcomes. 

AI: From Detection to Action

The evolution of AI as “the future of healthcare” or “the only show in town” was loud and clear, but the conversations about how to use AI have moved on. AI is increasingly progressing from detection, to reasoning, and now towards action. As AI agents become capable of embedding intelligence directly into workflows, the focus is shifting away from technical capability and towards operational impact.

One speaker commented that “the demo is not the deployment, and the output is not the outcome.” The message being that the real opportunity lies in turning AI into safe, trusted clinical tools that deliver measurable improvements in care delivery, productivity and outcomes. Strong governance helps to create trust, which leads to workflow integration. Integration improves adoption and adoption creates scale. However, return on investment remains critical. AI will only scale when organisations can clearly demonstrate value and when someone is willing to pay for that value.

One timely reminder acknowledged that both humans and AI make mistakes. Success is not about assuming perfection from either, but designing systems where errors become less likely, risks are managed appropriately and outcomes improve, which takes us back to strong governance.

The Evolution of GLP-1 Therapies 

The evolution of GLP-1 therapies and obesity care offered another example of healthcare's broader transition towards more personalised and preventative models. Conversations reflected a growing recognition that obesity is a complex chronic disease requiring integrated approaches that combine medication, behavioural support, education, lifestyle interventions and ongoing care. The focus is increasingly moving beyond weight loss alone towards quality weight loss, long-term health improvement and sustainable outcomes.

Concluding Thought

The commercial opportunities across healthcare innovation remains significant, but so too does the opportunity for research, investment, collaboration and scalable impact. However, the path to success increasingly depends on execution rather than invention alone.

Healthcare innovation is no longer just about building better technology. It is about aligning incentives, generating evidence, navigating regulation, securing reimbursement, integrating into workflows and delivering measurable outcomes at scale. The health span benefits are truly enormous and scalable, with life-changing potential on a global level. The key challenge for all innovators and policy makers is laying the foundations for successful integration of innovation across international healthcare infrastructure.

Stay up to date with sector developments — follow our Independent Health, Care & Life Sciences page.